Hexagon Nutrition Q1 FY27 profit up 25%: Key data

Key takeaway for investors

Hexagon Nutrition Limited reported a stronger start to FY27, with profitability and revenue both rising sharply year-on-year in the June quarter. The company said consolidated net profit increased 25% year-on-year to ₹80.73 million for Q1 FY27. Revenue from operations grew 43% to ₹1,043.06 million, indicating faster top-line expansion compared with the prior-year quarter. The update comes after the company’s IPO and listing on Indian stock exchanges in June 2026, a factor highlighted alongside the quarter’s momentum. Along with results, the board also set out a final dividend timeline and announced leadership changes. These corporate actions add additional datapoints for shareholders tracking governance and capital returns.

Q1 FY27 results: profit rises with faster revenue growth

The company’s consolidated performance for Q1 FY27 showed higher revenue translating into higher earnings. Revenue from operations was reported at ₹1,043.06 million compared with ₹728.61 million in Q1 FY26. Net profit rose to ₹80.73 million from ₹64.55 million over the same period. Total income increased to ₹1,063.84 million versus ₹742.37 million. Earnings per share (basic) stood at ₹0.67, up from ₹0.58. The disclosed changes indicate year-on-year growth across key lines, with revenue and total income expanding by a little over 43%.

Snapshot table: Q1 FY27 vs Q1 FY26 (consolidated)

Board meeting decisions on August 12, 2026

The Board of Directors met on August 12, 2026, alongside the quarterly results process. In that meeting, the board recommended a final dividend of ₹0.30 per equity share (face value ₹1 each) for the financial year ended March 31, 2026. The company also disclosed key corporate governance updates, including an appointment and a proposed re-appointment at the board level. These decisions typically require procedural milestones such as shareholder approval, record dates, and AGM timelines, all of which were specified in the disclosure.

Final dividend: amount, record date, and AGM timeline

The proposed final dividend of ₹0.30 per equity share is subject to shareholder approval. The company scheduled its 33rd Annual General Meeting (AGM) for September 22, 2026. It also fixed September 15, 2026 as the record date to determine eligibility for the dividend. These dates matter for investors who track entitlement timelines, especially around record date cut-offs. The disclosures indicate the dividend relates to the financial year ended March 31, 2026, rather than the ongoing FY27 period.

Leadership updates: appointment and re-appointment proposal

Hexagon Nutrition said its board appointed Mr. Raghunath Sawant as Additional Executive Director, effective August 12, 2026. Separately, the board recommended the re-appointment of Mr. Arun Purushottam Kelkar as Chairman and Director. Such announcements are closely watched because they can influence continuity and oversight at the company. The disclosure did not provide additional biographical or tenure details beyond the roles and effective date mentioned.

FY26 context: audited performance and margins

The company also reported figures for the year ended March 31, 2026, providing context for the latest quarterly numbers. Revenue from operations for FY26 was reported at ₹3,826.30 million. EBITDA for the year was ₹529.00 million, with an EBITDA margin of 13.83%. Profit after tax (PAT) for FY26 stood at ₹379.40 million, with a PAT margin of 9.9%. The company additionally stated that consolidated net profit for FY26 was ₹379.37 million, up 56% from ₹243.05 million in the previous year, alongside revenue from operations growth to ₹3,826.28 million from ₹3,249.29 million.

Quarter-end FY26 reference: Q4 numbers disclosed earlier

For the fourth quarter ended March 31, 2026, Hexagon Nutrition reported revenue of ₹1,150.40 million and PAT of ₹109.00 million. In a separate quarterly comparison table for Q4 FY26, the company reported total income of ₹1,189.96 million and net profit after tax of ₹109.04 million. Basic EPS for that quarter was shown at ₹0.99, with diluted EPS at ₹0.89. These data points help investors place Q1 FY27 in the context of the immediately preceding quarter’s scale.

Market and stock-data points mentioned in the update

The update included trading references around the company’s share price. It said Hexagon Nutrition was trading 3.29% higher at ₹66.00 compared with its last closing price, with the timestamp shown as August 11, 2026 at 09:03:17 AM IST. Another line stated the stock was trading at ₹66.00 as of Tue Aug 11 2026 03:33:17. The material also carried a separate reference that the current share price of Hexagon Nutrition is ₹64.15. These values were presented as reported in the source text, and readers typically cross-check live prices on exchange platforms due to intraday movements.

Why these results matter: growth plus corporate actions

The Q1 FY27 numbers show that revenue growth outpaced profit growth on a year-on-year basis, while EPS rose in line with the profit increase. Alongside the earnings update, the board’s final dividend recommendation provides a clear timeline for shareholders, with the record date and AGM date specified. The appointment of an Additional Executive Director and the recommendation to re-appoint the Chairman and Director indicate ongoing board-level changes being formalised through disclosures. Investors also have FY26 audited numbers, including EBITDA and PAT margins, to evaluate profitability alongside quarterly momentum.

Summary and what to watch next

Hexagon Nutrition’s Q1 FY27 update reported 43% YoY growth in revenue from operations to ₹1,043.06 million and a 25% rise in consolidated net profit to ₹80.73 million. The board recommended a ₹0.30 final dividend for FY26, with a September 15, 2026 record date and a September 22, 2026 AGM for shareholder approval. The company also announced a board appointment effective August 12, 2026 and a proposed re-appointment of its Chairman and Director. The next key checkpoint for shareholders, based on the disclosed schedule, is the 33rd AGM where the final dividend proposal will be placed for approval.